Company Analysis

Cellectar Biosciences, Inc. (CLRB)

Nasdaq: CLRB · Pharmaceutical Preparations · Florham Park, NJ · filing with the SEC since 2004
Grade5.0
◀ Past 3.0● Present 4.8▶ Future 6.3
6 est.

Who runs Cellectar Biosciences, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Caruso James V
President & CEO. First filing Aug 2015, latest Jul 8, 2026, 8 filings in all.
Officers reporting now
3
of 9 people with a filing in the last fifteen months
Directors reporting now
6
20 people on the record since 2014
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Caruso James VPresident & CEOAug 2015Jul 8, 2026none
Kolean Chad JCFOAug 2014Jul 8, 2026none
Longcor JarrodChief Operating OfficerAug 2016Jul 8, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Loren StefandirectorAug 2015Jul 10, 2026none
Chanan-Khan AsherdirectorJul 2021Jul 8, 2026none
Driscoll Frederick WdirectorApr 2017Jul 8, 2026none
Gu AndrewdirectorJun 2026Jul 8, 2026none
Neis JohndirectorAug 2014Jul 8, 20261 · $0.00
Swirsky Douglas JdirectorApr 2017Jul 8, 2026none
Earlier names on the record14, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CLRB · research, not advice